SCHEDULE 13D

Company

Cocrystal Pharma, Inc.

Filed

May 25, 2021

Accession Number

0001513162-21-000078

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →